New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.

HONG KONG SAR - Media OutReach Newswire - 17 July 2025 - Cyberport successfully hosted the "AI x Data Forum" today. Centered on the theme "AI in Action, Data at the Core: Unlocking Infinite Potential" ...

Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the ...

A complete list of all the known layoffs in tech, from Big Tech to startups, broken down by month throughout 2024 and 2025.

On this news, Hims & Hers' stock price fell $22.24 per share, or 34.63%, to close at $41.98 per share on June 23, 2025.

Overview of Obesity Treatment MarketThe global Obesity Treatment Market is valued at USD 22.2 Billion in 2024 and is projected to reach a value of USD 194.1 Billion by 2035 at a CAGR (Compound Annual ...

Eli Lilly and Company’s LLY stock has declined 15.7% in the past year. The first-quarter earnings miss, guidance cut and some ...

The investment outlook has been uncertain thanks to factors like tariffs and trade wars, inflation concerns, a dispute ...

Hims & Hers, the high-flying online health company that rapidly grew from a buzzy startup selling Viagra to a ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...